Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filters

PublicationDisease areaApplication areaSample typeProducts

Dementia and Geriatric Cognitive Disorders, 2025
Causal Relationship Between Inflammatory Proteins and Alzheimer's Disease: A Two-sample Bidirectional Mendelian Randomization Study

Xu R., Gao Y.

Olink Target 96NeurologyPathophysiologyPlasma

The Oncologist, 2025
First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors

Powderly J., Gutierrez M., Balmanoukian A. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Signal Transduction and Targeted Therapy, 2025
Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis

Liu X., Zhuang C., Liu L. et al.

Olink Target 96OncologyImmunotherapyPathophysiologySerum

Scientific Reports, 2025
Childhood obesity and insulin resistance is correlated with gut microbiome serum protein: an integrated metagenomic and proteomic analysis

Liu L., Li M., Qin Y. et al.

Olink Target 96Metabolic DiseasesPathophysiologySerum

Brain, Behavior, & Immunity - Health, 2025
Bidirectional Mendelian randomization analysis of inflammatory factors and sleep related traits

Liao Z., Guo S., Wang K. et al.

Olink Target 96NeurologyPathophysiologyPlasma

International Journal of Surgery, 2025
Plasma proteomics profiles predict the risk of future aortic aneurysm and aortic dissection

Li M., He X., Gong W. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Clinical Cancer Research, 2025
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma

Jang H., Patel M., Wang D. et al.

Olink Explore HTOncologyImmunotherapyPathophysiologyPlasma

Andrology, 2025
Maternal, childhood and adolescent influences on Leydig cell functional capacity and circulating INSL3 concentration in young adults: Importance of childhood infections and body mass index

Ivell R., Tulumcu B., Alhujaili W. et al.

Olink Target 96EndocrinologyPathophysiologyPlasma

Cell Reports, 2025
Maternal obesity impairs fetal brown adipogenesis by attenuating fetal FGF21 signaling

Hua L., Shen W., Gao D. et al.

Olink Target 48 MouseMetabolic DiseasesPathophysiologyMouse Serum

Diabetologia, 2025
Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters

Herder C., Zhu A., Schmitt A. et al.

Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPatient StratificationPlasma

Hearing Research, 2025
Investigating the causal relationship between circulating inflammatory proteins and tinnitus: Insights from a Mendelian Randomization study

He S., Wei M., Meng D. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Nature Communications, 2025
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial

Hansen J., Israelsen M., Nishijima S. et al.

Olink Target 96HepatologyPathophysiologyPlasma

The Oncologist, 2025
First-in-human phase I open-label study of the anti–TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors

Gutierrez M., Tang S., Powderly J. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Clinical Kidney Journal, 2025
New biomarkers of inflammation associated to hemodialysis

Guerrero F., Carmona A., Jiménez M. et al.

Olink Target 96CVDNephrologyPathophysiologyPlasma

Cardiovascular Diabetology, 2025
Single nuclei RNA-sequencing unveils alveolar macrophages as drivers of endothelial damage in obese HFpEF-related pulmonary hypertension

Gorica E., Spezzini J., Papadopoulou I. et al.

Olink Target 96 MouseMetabolic DiseasesCVDPathophysiologyMouse Serum

Alzheimer's Research & Therapy, 2025
Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial

Faridar A., Gamez N., Li D. et al.

Olink Target 48NeurologyPathophysiologyPlasma

World Journal of Otorhinolaryngology - Head and Neck Surgery, 2025
Integrative Analysis of Plasma Proteome and Genome Reveals Novel Drug Targets for Chronic Rhinosinusitis and Nasal Polyps

Zhou E., Luo S., Xiao Y. et al.

Olink Target 96Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Addiction Biology, 2025
Protein Associations With Alcohol Consumption and Genetic Risk for Alcohol‐Related Sociomedical Conditions

Drouard G., Palviainen T., Kuo C. et al.

Olink Explore 3072/384Other Diseases & SyndromesPathophysiologyPatient StratificationPlasma

npj Precision Oncology, 2025
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns

Daher-Ghanem N., Sharon S., Tao D. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationTissue Supernatant

RMD Open, 2025
Molecular insights into the relationship between sustained CRP elevation and endothelial dysfunction in axial spondyloarthritis

Cuesta-López L., Arias-de la Rosa I., Martín-Salazar J. et al.

Olink Target 96Immunological & Inflammatory DiseasesCVDPathophysiologySerum

2893 publications